As of May 25
| -1.30 / -5.34%|
The 5 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 12.00. The median estimate represents a -26.25% decrease from the last price of 23.05.
The current consensus among 5 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.